Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$832M |
| 2 |
Johnson & Johnson
JNJ
|
+$706M |
| 3 |
Datadog
DDOG
|
+$549M |
| 4 |
Amazon
AMZN
|
+$442M |
| 5 |
Eli Lilly
LLY
|
+$372M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Workday
WDAY
|
+$1.22B |
| 2 |
AbbVie
ABBV
|
+$1.07B |
| 3 |
Advanced Micro Devices
AMD
|
+$817M |
| 4 |
Amgen
AMGN
|
+$706M |
| 5 |
Honeywell
HON
|
+$659M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.69% |
| 2 | Healthcare | 17.58% |
| 3 | Consumer Discretionary | 10.69% |
| 4 | Financials | 10.23% |
| 5 | Communication Services | 9.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
Mesa Laboratories
MLAB
$551M
| $11.4M | 0.01% |
86,286
+8,092
| +10% | +$993K |
|
702
Bunge Global
BG
$20.9B
| $11.1M | 0.01% |
143,289
+117,699
| +460% | +$10.3M |
|
703
Blue Bird Corp
BLBD
$2.29B
| $11M | 0.01% |
285,583
+227,928
| +395% | +$9.52M |
|
704
The Ensign Group
ENSG
$10.6B
| $11M | 0.01% |
82,849
+11,953
| +17% | +$1.74M |
|
705
The Mosaic Company
MOS
$7.19B
| $11M | 0.01% |
447,748
+174,748
| +64% | +$4.57M |
|
|
WCC
706
WESCO International
WCC
$15.1B
| $11M | 0.01% |
60,527
+23,142
| +62% | +$4.38M |
|
707
GE Vernova
GEV
$240B
| $10.9M | 0.01% |
33,013
+132
| +0.4% | +$41.3K |
|
708
Southern Company
SO
$108B
| $10.9M | 0.01% |
131,814
+10,481
| +9% | +$920K |
|
709
Viper Energy
VNOM
$8.43B
| $10.8M | 0.01% |
220,936
+32,171
| +17% | +$1.66M |
|
710
EPAM Systems
EPAM
$5.58B
| $10.8M | 0.01% |
46,094
+39,383
| +587% | +$8.76M |
|
711
Wheaton Precious Metals
WPM
$49.7B
| $10.7M | 0.01% |
189,957
+107,413
| +130% | +$6.65M |
|
712
Newmont
NEM
$96.2B
| $10.6M | 0.01% |
283,695
-253,749
| -47% | -$11.6M |
|
713
Duke Energy
DUK
$101B
| $10.5M | 0.01% |
97,906
+970
| +1% | +$110K |
|
714
Cameco
CCJ
$36.8B
| $10.5M | 0.01% |
204,752
+123,855
| +153% | +$6.75M |
|
715
Manchester United
MANU
$4.03B
| $10.5M | 0.01% |
606,313
-8,652
| -1% | -$146K |
|
716
Mondelez International
MDLZ
$82.9B
| $10.4M | 0.01% |
174,301
-37,126
| -18% | -$2.46M |
|
717
Charles River Laboratories
CRL
$11.3B
| $10.4M | 0.01% |
56,288
+10,270
| +22% | +$1.98M |
|
718
Sherwin-Williams
SHW
$83.5B
| $10.4M | 0.01% |
30,513
-502
| -2% | -$187K |
|
|
TMHC
719
DELISTED
Taylor Morrison
TMHC
| $10.3M | 0.01% |
168,604
+89,403
| +113% | +$6.1M |
|
|
CTLP
720
DELISTED
Cantaloupe
CTLP
| $10.3M | 0.01% |
1,085,046
+930,061
| +600% | +$8.47M |
|
|
PRA
721
DELISTED
ProAssurance
PRA
| $10.3M | 0.01% |
645,358
+621,935
| +2,655% | +$9.89M |
|
722
Cigna
CI
$78.4B
| $10.3M | 0.01% |
37,119
-108
| -0.3% | -$34.4K |
|
723
Under Armour Class C
UA
$2.95B
| $10.2M | 0.01% |
1,374,220
+1,287,088
| +1,477% | +$10.7M |
|
724
Alcoa
AA
$11.3B
| $10.2M | 0.01% |
269,390
-79,951
| -23% | -$3.32M |
|
725
Kinross Gold
KGC
$27.7B
| $10.2M | 0.01% |
1,095,044
+993,913
| +983% | +$9.8M |
|
Similar funds
Janus Henderson Group's Q4 2024 Portfolio in Review
As of Q4 2024, Janus Henderson Group held 2,620 positions worth $197B, up 0.7% from $195B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Janus Henderson Group's Q4 2024 filing shows 92 new, 801 increased, 713 reduced and 96 closed positions. Its largest new stake was Lam Research: 10,967,975 shares worth $792M. The largest sale was Workday, an estimated $1.22B.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 34% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q4 2024 buy was Lam Research: 10,967,975 shares worth $792M.
- Janus Henderson Group added most to Johnson & Johnson in Q4 2024, an estimated $706M increase.
- Janus Henderson Group's biggest Q4 2024 reduction was Workday, cutting an estimated $1.22B.
- Janus Henderson Group fully exited Coca-Cola Europacific Partners in Q4 2024, selling an estimated $52.4M.
- Janus Henderson Group's ten largest holdings make up 32% of its $197B portfolio in Q4 2024.
- Janus Henderson Group opened 92 new positions and closed 96 in Q4 2024.
- Janus Henderson Group's portfolio value rose 0.7% quarter-over-quarter to $197B.
Based on Janus Henderson Group's 13F filing for Q4 2024, filed 14 Feb 2025.